GGiantBullStocks

Head to head

Halozyme Therapeutics, Inc. (HALO)vsPfizer, Inc. (PFE)

Price & valuation

MetricHALOPFE
Price$103.12$26.76
Change+20.24%+2.14%
Market cap
P/E ratio
EPS
52-week high
52-week low
Volume7,529,97236,137,077

Latest annual financials

MetricHALOPFE
Revenue$1.4B$62.58B
Net income$316.89M$7.77B
EPS$2.56$1.36